Study to Evaluate sUA Lowering Activity, Safety and Efficacy of Oral Ulodesine Added to Allopurinol
Clinical trial NCT01265264 · COMPLETED
Trial details
- NCT number
- NCT01265264
- Sponsor
- BioCryst Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-12-01
- Primary completion
- 2012-07-01
- Enrollment
- 279
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.